V

VistaGen Therapeutics
D

VTGN

2.21000
USD
-0.09
(-3.91%)
مغلق
حجم التداول
0
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
63,785,208
أصول ذات صلة
ABBV
ABBV
-1.290
(-0.67%)
191.070 USD
A
APVO
-0.26000
(-5.70%)
4.30000 USD
C
CLDX
0.890
(4.37%)
21.240 USD
GILD
GILD
-2.080
(-1.86%)
110.010 USD
M
MNKD
-0.11500
(-3.01%)
3.70500 USD
MRK
MRK
-0.050
(-0.06%)
81.740 USD
S
SUPN
-0.775
(-2.36%)
32.000 USD
T
TBPH
0.100
(0.94%)
10.710 USD
المزيد
الأخبار المقالات

العنوان: VistaGen Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.